Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06332547

Transfusion in Cardiac Valve Surgery

This prospective, randomized controlled study is aimed to figure out suitable transfusion threshold in patients undergoing cardiac valve surgery under cardiopulmonary bypass(CPB). Patients are randomly assigned to restrictive and liberal transfusion group and receive blood transfusion during and after surgery. Compare primary and secondary outcomes of two groups.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, 510145, China

Location contact

He Biaochuan, Phd

PRINCIPAL_INVESTIGATOR

Huang Huanlei, Phd

CONTACT

[email protected]

765 714 9765

Huang huanlei, Phd

PRINCIPAL_INVESTIGATOR

Wang Qiuji, MD

PRINCIPAL_INVESTIGATOR

Wang Zhenzhong, MD

PRINCIPAL_INVESTIGATOR

Zhang Zhaolong, BD

PRINCIPAL_INVESTIGATOR

Zhao Junfei, Phd

PRINCIPAL_INVESTIGATOR

About this study

Patients are randomly assigned to restrictive-threshold group and liberal-threshold group before cardiac group. Patients are included in this research when their Hct meets 24% during CPB.

Arterial blood gas analysis will be done in 0.5h, 1.5h, 2.5h, 3.5h...after CPB start and 0.5h before CPB finish.

Arterial blood gas analysis will be done every 4h in intensive care unit(ICU) and everyday in general ward.

Restrictive-threshold group: The transfusion threshold is Hemoglobin(Hb) ≤ 6.0g/dL or Hct ≤ 18% during CPB; postoperative Hb ≤ 7.0g/dL or Hct ≤ 21% in ICU or general ward.

Liberal-threshold group: The transfusion threshold is Hb ≤ 8.0g/dL or Hct ≤ 24% during CPB; postoperative Hb ≤ 10.0g/dL or Hct ≤ 30% in ICU or general ward.

If the Hb or Hct fall below the threshold at any time, 2 unit of blood cells is administered as soon as possible. Test Hb or Hct again, if is under the threshold 2 unit blood cells will be given until reach the threshold.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All cardiac valve surgical patients undergoing CPB, isolated valve procedures Informed consent obtained

Exclusion criteria

  • Pregnant or maternal women Age less than 18 years or more than 80 years Undergo coronary artery bypass or large cardiac vessels procedure Emergencies Have been attended other researches Unable to receive blood for religious reasons Drug addict or malignant tumor patient

Treatment and study plan

Restrictive Transfusion Strategy

Other

Blood transfusion at HCT less than 21% or Hb less than 6.0g/dL during CPB, at HCT less than 21% or Hb less than 7.0g/dL in ICU or general ward after surgery

Liberal transfusion strategy

Other

Blood transfusion at HCT less than 24% or Hb less than 8.0g/dL during CPB, at HCT less than 30% or Hb less than 10.0g/dL in ICU or general ward after surgery

Primary outcomes

  1. A composite of postoperative morbidity and mortality

    Time frame: Postoperative 6 months

    The composite components are postoperative mortality, infectious morbidity(wound infection, septicemia, or sepsis), ischemic event(myocardial infarction, stroke, renal infraction, bowel infraction )

Secondary outcomes

  1. Rate of reoperation

    Time frame: Postoperative 6 months

  2. Length of ICU Stays

    Time frame: From date of the end of operation until the date of discharging from ICU or date of death from any cause, whichever comes first, assessed up to 2 months.

  3. Length of Postoperative Hospital Stay

    Time frame: From date of discharging from ICU until the date of discharging from hospital or date of death from any cause, whichever comes first, assessed up to 2 months.

  4. Number of Blood Transfusion

    Time frame: From date of beginning of surgery until the date of discharging from hospital or date of death from any cause, whichever comes first, assessed up to 3 months.

  5. Duration of mechanical ventilation

    Time frame: From date of the end of surgery until the date of discharging from ICU or date of death from any cause, whichever comes first, assessed up to 2 months.

  6. Postoperative thoracic fluid volume in the first 24 hours

    Time frame: The first 24 hours after surgery

  7. Number of participants with postoperative atrial fibrillation

    Time frame: Postoperative 6 months

  8. Number of participants with new-onset renal failure with dialysis

    Time frame: Postoperative 6 months

  9. Number of participants with acute kidney injury

    Time frame: Postoperative 6 months

  10. Number of participants with delirium

    Time frame: Postoperative 6 months

  11. Hospitalization expense

    Time frame: From date of being admitted to hospital until the date of discharging from hospital or date of death from any cause, whichever comes first, assessed up to 3 months

Study contacts

Contact information is provided by the study sponsor or research team.

Huang Huanlei, Phd

CONTACT

[email protected]

765-714-9765

Zhang Zhaolong, BD

CONTACT

[email protected]

765-714-9765

Sponsors and collaborators

Lead sponsor

Guangdong Provincial People's Hospital

Other

Registry information

Official study title

A Multicenter Prospective, Randomized Controlled Study of Different Transfusion Thresholds in Cardiac Valve Surgery

Acronym: TICVS

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Mar 27, 2024
Registry last updated
Mar 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.